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associated with depression
Margarita Rivera1,2 and Peter McGuffin2*Abstract
Major depressive disorder is among the leading causes
of disease burden and disability, as well as a major
public health concern worldwide. Despite its substantial
heritability, no robustly replicated genetic risk loci had
been found until recently. Now, a new study has
identified, and replicated, two variants associated with
an increased risk for this disorder. The success of this
study appears to lie in the use of low-coverage
sequencing, instead of microarrays, and in minimizing
phenotypic and genetic heterogeneity.ated with higher heritability [3]. Until comparatively
recently, genetic association studies have focused mainlyThe pursuit of a single genetic cause
Major depressive disorder (MDD) is one of the most
common mental illnesses and the second-leading cause
of disability worldwide, making it the most frequent
cause of absenteeism from work and a major contributor
to the burden on healthcare systems [1]. Numerous
attempts had been made to pin down a single simple
genetic cause, but no significant associations had been
found. Instead, the recent focus had begun to shift to
viewing depression as a complex disease, with an in-
creasing emphasis on the interplay between multiple
genes and environmental factors. However, in an art-
icle published recently in Nature, the China, Oxford
and Virginia Commonwealth University Experimental
Research on Genetic Epidemiology (CONVERGE) con-
sortium has identified, and replicated in an independent
sample, two variants associated with an increase in risk
of MDD [2].
There are several potential explanations both for why
previous studies failed to identify loci that are signifi-
cantly associated with depression and for the success of
the CONVERGE group. One key factor seems to lie in* Correspondence: peter.mcguffin@kcl.ac.uk
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depression and the choice of low-coverage sequencing
by CONVERGE. Here, we discuss these factors and their
implications for future studies.The genetic basis of depression
Family, twin and, to a lesser extent, adoption studies
provide compelling evidence that genetic factors are
involved in susceptibility to MDD [3]. Heritability esti-
mates range from 17–75 %, with a mean of 37 %, and
there is evidence that severity and recurrence are associ-
on candidate genes — for example, those involved in
neurotransmission or in the hypothalamic–pituitary–
adrenal (HPA) axis. Almost 200 genes have been in-
vestigated with this approach, although only a few
findings have been replicated and yielded significant
results [4]. As with other common familial disorders, the
emphasis subsequently shifted to genome-wide associ-
ation studies (GWAS). These have been less successful so
far in finding robust evidence for genetic loci that con-
tribute to susceptibility to MDD than has been the case
in other psychiatric disorders such as schizophrenia and
bipolar disorder [5]. A recent mega-analysis conducted
on eight GWAS, including 9240 MDD cases and
9519 controls, analyzed more than 1.2 million single-
nucleotide polymorphisms (SNPs) in the discovery
phase but yielded no convincing results of genome-wide
significance (at P < 5 × 10−8) [5].
There are several plausible explanations for this fail-
ure. The first is that diagnostic and/or etiological hetero-
geneity has been a barrier to detection. For example,
milder forms of depression might not be influenced by
the same genetic risk factors as more-severe forms of
the disorder, and environmental factors could be more
important in some cases of depression compared with
others. Another factor is that the common variants con-
tributing to depression might have very small genetic
effects, and so even-larger sample sizes are required tohis article is distributed under the terms of the Creative Commons
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
um, provided you give appropriate credit to the original author(s) and the
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searches have been insufficiently sensitive to detect rare
types of structural variation with possibly larger effects,
such as copy number alterations (CNAs). Failure to take
into account environmental factors that could act in
combination with genetic risk factors might also explain
the failure to detect the latter, and methodological fac-
tors, such as insufficient quality control in combining
samples and multiple testing issues, might have stood in
the way [6, 7].
The COVERGE consortium was able to overcome
these limitations and was able to identify new associ-
ations. It recruited 5303 Han Chinese women with
recurrent MDD and 5337 healthy control individuals
from 58 Chinese hospitals. All the participants were
genotyped using a low-coverage sequencing method.
The results showed two loci significantly associated
with MDD at a genome-wide level on chromosome 10,
one near the SIRT1 gene (rs12415800; P = 1.92 × 10−8) and
the other in an intron of the LHPP gene (rs35936514;
P = 1.27 × 10−8). To confirm this finding, the authors
used a different method to re-genotype these individ-
uals, and the results supported the association of
these two SNPs with MDD [2]. These associations
were also replicated in an independent cohort of 3231
Han Chinese women with recurrent MDD and 3186
controls, confirming that the SNPs at SIRT1 and LHPP
genes are significantly associated with MDD [2].
The authors then focused on cases within the
CONVERGE consortium diagnosed with melancholia, a
more severe and possibly more heritable subtype of MDD.
The results showed genome-wide significant associations
with the same two loci on chromosome 10. Interestingly,
the association at the SIRT1 gene was more significant than
when MDD as a whole was studied (P = 2.95 × 10−10) [2].
The SIRT1 gene, which encodes an NAD-dependent pro-
tein deacetylase, is known to be involved in mitochondrial
metabolism [8], and intriguingly the same group has re-
ported recently that MDD is associated with an increased
amount of mitochondrial DNA [9].
Unfortunately, the CONVERGE group failed to repli-
cate their top signals in the Psychiatric Genomics
Consortium (PGC) mega-analysis of European cohorts
[5]. Furthermore, the PGC found no evidence implicat-
ing mitochondrial metabolism when they studied over
60,000 participants and performed pathway analysis in
MDD and other major psychiatric disorders [10]. One
important factor to be taken into consideration is that
the variants found associated with MDD in Chinese
individuals are less common in European populations.
Why did the CONVERGE study succeed?
One might argue that a key question concerns why the
CONVERGE study succeeded when the PGC and othersso far have failed. The CONVERGE study attempted to
minimize phenotypic and genetic heterogeneity by
choosing women only and concentrating on more-severe
hospital-treated cases of MDD from China. The focus
was thus on a less prevalent type of depression than that
included in the PGC from Europe and the USA,
which included population-ascertained as well as
clinically ascertained samples. The participants in the
CONVERGE study were genotyped using a low-coverage
sequencing approach rather than a microarray-based
GWAS. This is the first study published, to date, using
this approach to investigate the genetic contribution to
MDD. The authors of the CONVERGE study argue that
the method allowed them to capture a greater repertoire
of variants than can be detected by commercially avail-
able SNP-based genotyping arrays.
Concluding remarks
The results of the CONVERGE study are provocative,
but it is important to consider what needs to be done
next to clarify the molecular-genetic contribution to
MDD. MDD is a much more common disorder (or
group of disorders) than schizophrenia or bipolar dis-
order, in which the PGC approach of combining
samples from multiple centres has been successful.
Perhaps, therefore, larger-scale ascertainment of more-
homogeneous, more severely affected samples is the key
to enhancing the chances of success in MDD. Further
replications in very large independent cohorts, as well as
carefully matched case–control samples from a different
ethnic origin, would be desirable. It would also be of
interest to extend genomic analysis of MDD to new ap-
proaches such as gene–gene and gene–environment in-
teractions and pathway analysis. Thus, the intriguing
CONVERGE study findings open the door to a range of
further studies that could help to identify biological path-
ways and provide therapeutic targets for MDD, a com-
mon illness with major impact on public health and on
the lives of many people.
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